Credit Suisse’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $3.1M | Buy |
11,603
+1,075
| +10% | +$287K | ﹤0.01% | 1582 |
|
2023
Q4 | $2.44M | Sell |
10,528
-172
| -2% | -$39.8K | ﹤0.01% | 1763 |
|
2023
Q3 | $1.56M | Sell |
10,700
-3,349
| -24% | -$489K | ﹤0.01% | 1977 |
|
2023
Q2 | $3.25M | Buy |
14,049
+3,559
| +34% | +$822K | ﹤0.01% | 1603 |
|
2023
Q1 | $2.54M | Buy |
10,490
+484
| +5% | +$117K | ﹤0.01% | 1717 |
|
2022
Q4 | $2.9M | Sell |
10,006
-62
| -0.6% | -$18K | ﹤0.01% | 1647 |
|
2022
Q3 | $655K | Buy |
10,068
+1,595
| +19% | +$104K | ﹤0.01% | 2608 |
|
2022
Q2 | $606K | Buy |
8,473
+279
| +3% | +$20K | ﹤0.01% | 2706 |
|
2022
Q1 | $804K | Buy |
8,194
+1,541
| +23% | +$151K | ﹤0.01% | 2663 |
|
2021
Q4 | $564K | Sell |
6,653
-1,059
| -14% | -$89.8K | ﹤0.01% | 2947 |
|
2021
Q3 | $615K | Buy |
7,712
+1,546
| +25% | +$123K | ﹤0.01% | 2874 |
|
2021
Q2 | $601K | Sell |
6,166
-2,856
| -32% | -$278K | ﹤0.01% | 2920 |
|
2021
Q1 | $1.06M | Sell |
9,022
-5,970
| -40% | -$698K | ﹤0.01% | 2541 |
|
2020
Q4 | $1.67M | Buy |
14,992
+4,739
| +46% | +$527K | ﹤0.01% | 2241 |
|
2020
Q3 | $1.22M | Sell |
10,253
-12,043
| -54% | -$1.43M | ﹤0.01% | 2138 |
|
2020
Q2 | $2.53M | Buy |
22,296
+9,363
| +72% | +$1.06M | ﹤0.01% | 1698 |
|
2020
Q1 | $863K | Sell |
12,933
-8,865
| -41% | -$592K | ﹤0.01% | 2218 |
|
2019
Q4 | $1.99M | Buy |
21,798
+13,335
| +158% | +$1.21M | ﹤0.01% | 2040 |
|
2019
Q3 | $729K | Buy |
8,463
+1,907
| +29% | +$164K | ﹤0.01% | 2591 |
|
2019
Q2 | $687K | Sell |
6,556
-410
| -6% | -$43K | ﹤0.01% | 2599 |
|
2019
Q1 | $871K | Sell |
6,966
-123
| -2% | -$15.4K | ﹤0.01% | 2456 |
|
2018
Q4 | $799K | Buy |
7,089
+1,349
| +24% | +$152K | ﹤0.01% | 2460 |
|
2018
Q3 | $1.23M | Sell |
5,740
-3,048
| -35% | -$653K | ﹤0.01% | 2279 |
|
2018
Q2 | $2.46M | Buy |
8,788
+2,995
| +52% | +$838K | ﹤0.01% | 1921 |
|
2018
Q1 | $677K | Buy |
5,793
+757
| +15% | +$88.5K | ﹤0.01% | 2793 |
|
2017
Q4 | $462K | Buy |
+5,036
| New | +$462K | ﹤0.01% | 2987 |
|
2016
Q3 | – | Sell |
-7,601
| Closed | -$69K | – | 3798 |
|
2016
Q2 | $69K | Buy |
7,601
+7,007
| +1,180% | +$63.6K | ﹤0.01% | 3807 |
|
2016
Q1 | $5K | Sell |
594
-318
| -35% | -$2.68K | ﹤0.01% | 3644 |
|
2015
Q4 | $11K | Sell |
912
-5
| -0.5% | -$60 | ﹤0.01% | 3955 |
|
2015
Q3 | $56K | Sell |
917
-3,431
| -79% | -$210K | ﹤0.01% | 3944 |
|
2015
Q2 | $340K | Buy |
4,348
+2,448
| +129% | +$191K | ﹤0.01% | 3674 |
|
2015
Q1 | $129K | Sell |
1,900
-2,660
| -58% | -$181K | ﹤0.01% | 3903 |
|
2014
Q4 | $423K | Sell |
4,560
-1,223
| -21% | -$113K | ﹤0.01% | 3465 |
|
2014
Q3 | $608K | Sell |
5,783
-1,174
| -17% | -$123K | ﹤0.01% | 3110 |
|
2014
Q2 | $996K | Buy |
6,957
+914
| +15% | +$131K | ﹤0.01% | 2890 |
|
2014
Q1 | $912K | Buy |
6,043
+786
| +15% | +$119K | ﹤0.01% | 2870 |
|
2013
Q4 | $964K | Buy |
5,257
+1,401
| +36% | +$257K | ﹤0.01% | 2911 |
|
2013
Q3 | $851K | Sell |
3,856
-3,430
| -47% | -$757K | ﹤0.01% | 2690 |
|
2013
Q2 | $1.27M | Buy |
+7,286
| New | +$1.27M | ﹤0.01% | 2264 |
|